FDA Inspection 1134998 — QED Therapeutics, Inc.
The FDA completed an inspection of QED Therapeutics, Inc. on December 21, 2020 in Brisbane, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 21, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Brisbane, CA (United States)
Additional Details
Sponsor, Contract Research Organization